OMTHERA PHARMACEUTICALS INC

Inactive Instrument

All News Omthera Pharmaceuticals Inc

Equities

US68217A1034

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2013	Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	RE
2013	Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	RE

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Omthera Pharmaceuticals Inc : FDA accepts new drug application for investigational compound Epanova for the treatment of severe hypertriglyceridaemia	20/09/13	PU
Omthera Pharmaceuticals Inc : Omthera Stockholders Approve Acquisition by AstraZeneca	16/07/13	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces NDA Submission for Epanova(TM) for the Treatment of Patients with Very High Triglycerides	09/07/13	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Termination Of Antitrust Waiting Period	27/06/13	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals Announces Record Date and Meeting Date for Special Meeting of Stockholders	13/06/13	PR
Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	10/06/13	RE
Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion	10/06/13	RE
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals, Inc. Stockholders Seeking More Money, Information in Buyout Should Contact Deans & Lyons Law Firm	30/05/13	PR
GlaxoSmithKline plc : GSK bets on chimp virus with $321 million vaccines buy	29/05/13	RE
Omthera Pharmaceuticals Inc : Law Firm Brower Piven Announces Investigation of Omthera Pharmaceuticals, Inc. Proposed Buyout	29/05/13	BU
Omthera Pharmaceuticals Inc : Ryan & Maniskas, LLP Announces Investigation of Omthera Pharmaceuticals, Inc.	29/05/13	PR
Omthera Pharmaceuticals Inc : OMTHERA PHARMACEUTICALS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Omthera Pharmaceuticals, Inc. Following Announcement of Proposed Sale of Company to AstraZeneca	29/05/13	BU
AstraZeneca plc : AstraZeneca buys heart firm Omthera for up to $443 million	28/05/13	RE
AstraZeneca plc : AstraZeneca buys heart firm Omthera for up to $443 million	28/05/13	RE
Omthera Pharmaceuticals Inc : AstraZeneca to Acquire Omthera Pharmaceuticals Including NDA-Ready Novel Dyslipidemia Treatment to Complement Cardiovascular Portfolio	28/05/13	PR
Omthera Pharmaceuticals Inc : Omthera Pharmaceuticals, Inc. Announces Closing of Initial Public Offering	16/04/13	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
Stock
News Omthera Pharmaceuticals Inc

Our Free Content Help you Secure and Increase the Performance of Your Investments

Secure my Investments

fermer